Funded Grants

PI Name PI Organization Title Sort descending Grant Number Initiative Program Official
Siminski, Suzanne M.

Frontier Sci & Technology Rsch Fdn, Inc
United States

CASCADE Coordinating Center 5U24CA275417-02 Silvina Frech, Ph.D., M.S.
Dashwood, Roderick H

Texas A&M University Health Science Ctr
United States

CCAR2 as a Target for Prevention of Colorectal Cancer. 5R01CA122959-11 Sharon Ross, Ph.D., M.P.H.
Gudas, Lorraine J

Weill Medical Coll Of Cornell Univ
United States

CD 1530, an RAR Gamma Agonist for Oral Cavity Squamous Cell Carcinoma Prevention 1R01CA270248-01A1 Winfred Malone, Ph.D., M.P.H.
Terry, Kathryn L

Brigham And Women'S Hospital
United States

Changing Contraceptive Patterns and Ovarian Cancer Risk 5R01CA258679-04 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Goli Samimi, Ph.D., M.P.H.
Moyer, Matthew T.

Pennsylvania State Univ Hershey Med Ctr
United States

CHARM 2: Chemotherapy for ablation and resolution of mucinous pancreatic cysts: a prospective, randomized, double-blind, multi-center clinical trial 5R01CA222648-05 Asad Umar, D.V.M., Ph.D.
Bertozzi, Carolyn

Stanford University
United States

Chemical Glycoproteomics 5R01CA200423-20 Richard Mazurchuk, Ph.D.
Eibl, Guido Erwin Michael

University Of California Los Angeles
United States

Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma 5P01CA236585-05 Sharon Ross, Ph.D., M.P.H.
El-Bayoumy, Karam E

Pennsylvania State Univ Hershey Med Ctr
United States

Chemoprevention by Black Raspberry of Oral Cancer Induced by Tobacco Carcinogens: Translational Studies 5R01CA173465-10 Gabriela Riscuta, M.D., C.N.S.
Shen, Qiang

Lsu Health Sciences Center
United States

Chemoprevention of Breast Cancer by Targeting Glucose Metabolism with HJC0152 5R01CA226001-06 Marjorie Perloff, M.D.
You, Ming

Methodist Hospital Research Institute
United States

Chemoprevention of lung cancer by targeting lonidamine to mitochondria 5R01CA232433-05 John Clifford, Ph.D.